Page last updated: 2024-08-24

sparfloxacin and Sinusitis

sparfloxacin has been researched along with Sinusitis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berche, P; Gaillot, O1
Berche, P; Gehanno, P1
Chuck, SK; Jung, R; Martin, SJ; Messick, CR; Meyer, JM; Pendland, SL1
Dorr, MB; Lipsky, BA; Magner, DJ; Talbot, GH1

Reviews

1 review(s) available for sparfloxacin and Sinusitis

ArticleYear
Levofloxacin and sparfloxacin: new quinolone antibiotics.
    The Annals of pharmacotherapy, 1998, Volume: 32, Issue:3

    Topics: Absorption; Anti-Infective Agents; Bronchitis; Drug Interactions; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Pneumonia; Quinolones; Sinusitis; Skin Diseases; Urinary Tract Infections

1998

Trials

1 trial(s) available for sparfloxacin and Sinusitis

ArticleYear
Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 37 Suppl A

    Topics: Acute Disease; Adult; Anti-Infective Agents; Cefuroxime; Cephalosporins; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Prodrugs; Quinolones; Sinusitis

1996

Other Studies

2 other study(ies) available for sparfloxacin and Sinusitis

ArticleYear
In vitro susceptibility to ciprofloxacin of bacterial strains isolated from chronic otitis media and chronic sinusitis.
    Drugs, 1995, Volume: 49 Suppl 2

    Topics: Adult; Anti-Infective Agents; Bacteria; Chronic Disease; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Otitis Media; Quinolones; Sinusitis

1995
Safety profile of sparfloxacin, a new fluoroquinolone antibiotic.
    Clinical therapeutics, 1999, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Data Interpretation, Statistical; Female; Fluoroquinolones; Heart Rate; Humans; Male; Middle Aged; Photosensitivity Disorders; Pneumonia, Bacterial; Quinolones; Sinusitis; Skin Diseases, Bacterial

1999